CureVac
Maren Prokopp is a financial and business process expert with extensive experience in various roles at CureVac since August 2016, including positions as Financial Expert SOX and Project Coordinator PMO. Prior experience includes creative project management at Halo Edutainment GmbH and project management roles at Eures GmbH and Transline Deutschland GmbH. Maren Prokopp holds a Bachelor of Arts degree in Romanische Sprachen, Literaturen und Linguistik from the University of Tübingen, completed in 2011.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.